Departament of Hypertension and Diabetes, Medical University of Gdansk, Poland.
Guy's Richard Dimbleby Department of Cancer Research, Kings College London, London, UK.
Clin Endocrinol (Oxf). 2021 Sep;95(3):369-377. doi: 10.1111/cen.14453. Epub 2021 May 3.
The literature on COVID-19-related thyroid complications has accumulated over the past year or so as the pandemic has accelerated throughout the world. In particular, several recent case reports have been published describing a possible correlation between COVID-19 disease and subacute thyroiditis (SAT). In this review, we briefly present one of our own patients and review the current published literature in this area up to January 2021, including analyses of major series of thyroid function tests in patients with significant COVID-19 infection. We conclude that while the great majority of patients with severe COVID-19 infection may show manifestations of the sick euthyroid syndrome, clinicians should be aware of the possibility of SAT, especially in the early weeks and months following even mild COVID-19 infection.
随着疫情在全球范围内的加速蔓延,过去一年左右,有关 COVID-19 相关甲状腺并发症的文献不断积累。特别是,最近发表了几篇病例报告,描述了 COVID-19 疾病与亚急性甲状腺炎 (SAT) 之间可能存在的相关性。在这篇综述中,我们简要介绍了我们自己的一位患者,并回顾了截至 2021 年 1 月的该领域的现有文献,包括对患有严重 COVID-19 感染的患者进行的甲状腺功能测试的主要系列分析。我们得出的结论是,虽然绝大多数患有严重 COVID-19 感染的患者可能表现出病态甲状腺功能正常综合征的特征,但临床医生应该意识到 SAT 的可能性,尤其是在 COVID-19 感染后甚至轻症的最初几周和几个月内。